论文部分内容阅读
目的探讨黛力新对功能性消化不良(FD)康复的影响。方法将例FD患者随机分为两组,研究组48例,用黛力新联合莫沙必利,对照组48例,单用莫沙必利。结果两组患者在治疗8周后症状改善,有效率分别为治疗组:91.7%,对照组68.8%,两组比较有效率差异有统计学意义(P<0.05)。结论黛力新对FD患者康复有显著疗效,值得推广。
Objective To investigate the effect of Deanxit on functional dyspepsia (FD) rehabilitation. Methods The patients with FD were randomly divided into two groups. The study group consisted of 48 cases with dextromethorphan combined with mosapride, the control group with 48 cases and mosapride alone. Results After treatment for 8 weeks, the symptoms of the two groups were improved. The effective rates were 91.7% in the treatment group and 68.8% in the control group, respectively. The difference between the two groups was statistically significant (P <0.05). Conclusion Deanxit has a significant effect on the rehabilitation of FD patients and is worth promoting.